Meetings

  • Return of Research Results: Report Release Webinar Date: July 10, 2018 (11:00 AM Eastern)

    Return of Research Results Consensus Study Report Release Webinar
  • Understanding Disparities in Access to Genomic Medicine: A Workshop Date: June 27, 2018 (8:30 AM Eastern)

    The Roundtable on Genomics and Precision Health hosted a public workshop on June 27, 2018 to explore disparities in access to genetic/genomic services that exist across different segments of the population (e.g., in medically underserved areas and populations, across different racial/ethnic groups, and socioeconomic levels). The workshop discussed model programs of care for diverse patient populations, with a focus on examining current challenges, approaches, and best practices for alleviating disparities in access, which may include the geographic distribution of providers and services and the potential role of telemedicine. Workshop discussions focused on insurance coverage for genetic/genomic services, along with the financial costs for patients of genetic testing and downstream care.
  • Harnessing Mobile Technology to Predict, Diagnose, Monitor, and Develop Treatments for Nervous System Disorders: A Workshop Date: June 5, 2018 - June 6, 2018 (1:30 PM Eastern)

    The Forum on Neuroscience and Nervous System Disorders will host a public workshop to help advance the appropriate use of devices and mobile technology to predict, diagnose, monitor, assess adherence, and develop treatments for CNS disorders
  • Advancing the Science of Patient Input in Medical Product R&D: Towards a Research Agenda - A Workshop Date: May 9, 2018 (8:30 AM Eastern)

    An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine (NASEM) will plan and conduct a three-part workshop series to be held over the course of a two-year period. As part of FDA's continued focus on building a national governance system for evidence generation, the proposed focus of these workshops will be on the generation and utilization of real-world evidence to evaluate efficacy, effectiveness, tolerability, and safety for both review of new indications and postapproval studies. These workshops would include presentations and perspectives from thought and knowledge leaders representing a range of disciplines, including but not limited to federal regulatory and funding agencies, clinical and academic medicine and research, medical professional organizations, the regulated biopharmaceutical industry, patients and patient-focused and disease-advocacy organizations, payers, consumer organizations, health systems, and other interested stakeholders that represent the myriad views of those involved in drug, biologic, and device discovery, development, translation, and regulation. The workshop audiences are expected to be similarly diverse, and they will have opportunities to engage in discussion during the workshops.
  • Engaging the Private Sector Health Care System in Building Capacity to Respond to Threats to the Public’s Health and National Security Date: March 20, 2018 - March 21, 2018 (8:30 AM Eastern)

    The National Academies of Sciences, Engineering, and Medicine will host a two-day public workshop on March 20-21, 2018 at the National Academies Building (NAS Auditorium) called Engaging the Private Sector Health Care System in Building Capacity to Respond to Threats to the Public’s Health and National Security. Through this workshop, the committee will bring together public and private sector partners to discuss approaches to aligning healthcare system incentives with the American public’s need for a healthcare system that is optimally prepared and scalable to manage acutely ill and injured patients during a disaster, public health emergency, or other mass casualty event.
  • Meeting 4: Committee to Review the Dietary Reference Intakes for Sodium and Potassium Open Session (Webinar) Date: March 9, 2018 (9:30 AM Eastern)

    The Committee to Review the Dietary Reference Intakes for Sodium and Potassium will be holding a public meeting on March 9, 2018 from 9:30 am – 10:30 am ET via web conference only. During this meeting, Dr. Shiriki Kumanyika from Drexel University will discuss health implications of sodium intake for different subpopulations and will answer questions from the committee members. To view this web-based public meeting, please register using the link on the right side of the page. Please direct any questions to Meredith Young at myoung@nas.edu. There will also be a public workshop on March 7, 2018 from 8:00 AM to 5:15 PM ET. For more information, please click here.
  • Public Workshop for the Committee to Review the Dietary Reference Intakes for Sodium and Potassium Date: March 7, 2018 (8:00 AM Eastern)

    The Committee to Review the Dietary Reference Intakes for Sodium and Potassium will hold a public workshop on March 7, 2018 from 8 AM to 5:15 PM ET at the Keck Center in Washington, DC (500 Fifth Street NW, Washington, DC 20001). Attendees may register to attend in-person or listen to the workshop online. Space for in-person attendance is limited and attendees may be asked to view the workshop from an overflow room, should we reach capacity. For in-person attendees there will be an opportunity to address the committee; each individual will have 3 minutes to make his or her remarks. If you are unable to attend the meeting please feel free to submit public comments at any time to NaKDRIReview@nas.edu. There will also be a web-based public session on March 9, 2018 from 9:30 to 10:30 AM ET. For more information, please click here.
  • Neuroforensics: Exploring the Legal Implications of Emerging Neurotechnologies—A Workshop Date: March 6, 2018 (8:00 AM Eastern)

    Neuroforensics: Exploring the Legal Implications of Emerging Neurotechnologies
  • Examining the Impact of Real-World Evidence on Medical Product Development: A Workshop Series | Workshop 2: Practical Approaches Date: March 6, 2018 - March 7, 2018 (8:00 AM Eastern)

    An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine (NASEM) will plan and conduct a three-part workshop series to be held over the course of a two-year period. As part of FDA's continued focus on building a national governance system for evidence generation, the proposed focus of these workshops will be on the generation and utilization of real-world evidence to evaluate efficacy, effectiveness, tolerability, and safety for both review of new indications and postapproval studies. These workshops would include presentations and perspectives from thought and knowledge leaders representing a range of disciplines, including but not limited to federal regulatory and funding agencies, clinical and academic medicine and research, medical professional organizations, the regulated biopharmaceutical industry, patients and patient-focused and disease-advocacy organizations, payers, consumer organizations, health systems, and other interested stakeholders that represent the myriad views of those involved in drug, biologic, and device discovery, development, translation, and regulation. The workshop audiences are expected to be similarly diverse, and they will have opportunities to engage in discussion during the workshops.
  • Fifth Meeting of the Committee on the Return of Individual-Specific Research Results Generated in Research Laboratories Date: February 20, 2018 - February 21, 2018 (8:30 AM Eastern)

    Fifth Meeting of the Return of Research Results Committee